Join former White House policy expert Joe Grogan as he cuts through the complexities of healthcare legislation and its real-world implications. Each episode of DC EKG aims to demystify the policies shaping our healthcare system, uncovering how these changes impact patients, providers, and payers across the country.
Dr. David Eagle, president of the American Independent Medical Practice Association and a hematologist-oncologist, joins host Joe Grogan to examine the decline of independent oncology practices in America. The episode documents a dramatic shift: independent practices provided 85% of cancer care in 2000 but now deliver…
Worth it if you care about healthcare policy, independent medicine, oncology practice economics, or how consolidation affects care delivery—but not if you need balanced debate or primary-source documentation.
Joe Grogan interviews John Desser, VP of Government Affairs at Health Equity (the nation's largest HSA provider), about market-based healthcare solutions and Health Savings Accounts as a path forward for U.S. healthcare reform. Desser brings 35 years of healthcare policy experience, including work in Senator McCain's…
Worth it if you're interested in healthcare policy history, HSAs, or market-based reform arguments, and don't mind a one-sided perspective from an industry advocate.
Elizabeth Chamblee Birch, a law professor and author of The Pain Brokers, discusses a massive healthcare fraud scheme that targeted over 100,000 women through stolen HIPAA-protected medical records. The scheme operated through call centers in India and South Florida that used stolen health data to convince women they…
Worth it if you care about healthcare fraud, women's health justice, litigation system vulnerabilities, or how private equity is reshaping legal practice.
Joe Grogan interviews John Bertrand, a veteran healthcare technology executive who led Digital Diagnostics to FDA approval and CMS reimbursement for an autonomous AI diagnostic device for diabetic retinopathy. Bertrand spent 13 years at Epic Systems before six years at Digital Diagnostics, and now works in supply…
Worth it if you're an entrepreneur in healthcare AI, a healthcare innovation investor, or someone curious about why promising medical AI products struggle to reach patients despite clinical merit.
